Werba Rubin Papier Wealth Management Gilead Sciences, Inc. Transaction History
Werba Rubin Papier Wealth Management
- $362 Billion
- Q2 2024
A detailed history of Werba Rubin Papier Wealth Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Werba Rubin Papier Wealth Management holds 13,728 shares of GILD stock, worth $1.16 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
13,728
Previous 13,486
1.79%
Holding current value
$1.16 Million
Previous $988 Million
4.65%
% of portfolio
0.26%
Previous 0.29%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
1,879Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$10.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.77 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.46 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.12 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.03 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $106B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...